Clin2
NCT03984461Possibly a fitRecruiting

Platelet-rich treatment with joint fluid or bone cells for arthritis

Osteoarthritis

Part of Bones, joints & muscles clinical trials.

This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
240 people
Ages
19 years to 79 years
Study type
Interventional

Who can take part

  • You can sign consent and follow all study instructions
  • You are at least 19 years old
  • You have osteoarthritis in a major joint, confirmed by a recent (within 1 year) x-ray or MRI
  • Your x-ray severity is mild to moderate (Kellgren and Lawrence grade 1–3), not grade 4
  • Your BMI is 35 or lower
  • You must be able to take anti-platelet medicine as your clinician advises

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02844764Recruiting· Phase 2
Cell therapy test for hip osteoarthritis pain and swelling

This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.

Grove City, Pennsylvania
NCT02844751Recruiting· Phase 2
Regenerative knee cell therapy for arthritis pain and swelling

This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.

Grove City, Pennsylvania
NCT02844738Recruiting· Phase 2
Cell therapy for shoulder osteoarthritis pain and inflammation

This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.

Grove City, Pennsylvania
NCT04238143Recruiting
Knee and other joint arthritis tissue therapy

This trial tests a regenerative therapy made from a patient’s own fat tissue (a “cellular” treatment) to reduce pain and improve function in arthritis-related problems. It may help people with inflammatory or degenerative arthritis changes, if they meet safety and tissue-donation requirements.

Valencia, California
NCT06451120Recruiting· Phase 2
Platelet-rich plasma injections for knee arthritis

This study tests whether platelet-rich plasma (PRP) injections can help knee arthritis in both younger and older adults. If you have knee pain from arthritis and haven't had other treatments recently, you might be able to join.

San Francisco, California
NCT07617233Not yet recruiting
Blood Markers Predicting Platelet-Rich Plasma Success for Knee Arthritis

This study examines whether certain blood cell patterns can predict who will benefit most from platelet-rich plasma (PRP)—an injection treatment made from your own blood—for knee osteoarthritis. If your blood markers match certain patterns, you may be more likely to experience pain relief and improved function.

Kyrenia

Hear when a new Osteoarthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.